Back to search
FDAFDA · Food and drugs·Recall number D-1167-2022

Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension, Rx, This is a compounded medication., Valor Compounding Pharmacy, 2461 Shattuck Ave., Berkeley, CA 94704,

Published June 15, 2022 · Recall initiated: April 15, 2022

Summary

FDA records drug Class I recall D-1167-2022, published June 15, 2022 and initiated April 15, 2022. Recalling firm: Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy; Status: Terminated; Reported quantity: 1,966 mLs in 12 oz; 2 oz; 16 oz and 6 oz bottles; Lot: Lot #: 03312022@29, BUD: 6/10/2022. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent drug

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy
Distributor
CA
Lot
Lot #: 03312022@29, BUD: 6/10/2022
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension, Rx, This is a compounded medication., Valor Compounding Pharmacy, 2461 Shattuck Ave., Berkeley, CA 94704, recalled?

Yes. FDA published recall D-1167-2022 on June 15, 2022. Reported hazard: Subpotent drug

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit